This inventor holds 1 USPTO granted patent. Top assignee: Geistlich Pharma. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Cornel Imhof: Innovator in Collagen Technology
Introduction
Cornel Imhof is a notable inventor based in Lucerne, Switzerland. He has made significant contributions to the field of biomedical materials, particularly in the development of collagen-based products. His innovative work focuses on enhancing soft tissue augmentation techniques in the oral region.
Latest Patents
Cornel Imhof holds a patent for a resilient resorbable chemically crosslinked collagen sponge. This sponge is designed for promoting soft tissue volume augmentation in the oral cavity. The sponge comprises 60-96% (w/w) collagen and 4-40% (w/w) elastin. It features interconnected pores with a median pore diameter between 50 and 90 µm and at least 80% porosity. The sponge has an onset temperature of 45 to 57°C and a density in the dry state ranging from 50 to 65 mg/cm. The patent also includes a process for preparing this collagen sponge and a method for its use as an implant in the oral cavity.
Career Highlights
Cornel Imhof is associated with Geistlich Pharma, a company known for its advancements in regenerative medicine. His work at Geistlich Pharma has been pivotal in developing innovative solutions for dental and orthopedic applications. His expertise in collagen technology has positioned him as a key figure in the industry.
Collaborations
Throughout his career, Cornel has collaborated with esteemed colleagues such as Lothar Schloesser and Niklaus Stiefel. These collaborations have further enriched his research and development efforts in the field of biomaterials.
Conclusion
Cornel Imhof's contributions to collagen technology and soft tissue augmentation are noteworthy. His innovative patent and work at Geistlich Pharma highlight his commitment to advancing medical solutions. His efforts continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile